KemPharm, Inc. (KMPH) Social Stream
KEMPHARM INC (KMPH) Price Targets From Analysts
Use the tables below to see what analysts covering KEMPHARM INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-01-20 | 2 | $28 | $10 | $19 | $5.81 | 227.02% |
| 2022-08-12 | 2 | $28 | $11 | $19.5 | $5.81 | 235.63% |
| 2022-08-17 | 2 | $28 | $10 | $19 | $5.81 | 227.02% |
| 2022-09-28 | 3 | $28 | $10 | $19.333 | $5.81 | 232.75% |
| 2022-11-14 | 3 | $28 | $10 | $19 | $5.81 | 227.02% |
| 2023-02-24 | 4 | $28 | $10 | $19.25 | $5.81 | 231.33% |
The Trend in the Analyst Price Target
KMPH's average price target has moved up $0.25 over the prior 21 months.
Over the past 49 weeks, KMPH's average upside potential has been 274.38%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-05-16 | 2 | 28 | 11 | 19.500 | 4.39 | 344.19% |
| 2022-06-02 | 2 | 28 | 11 | 19.500 | 4.73 | 312.26% |
| 2022-08-12 | 2 | 28 | 11 | 19.500 | 6.11 | 219.15% |
| 2022-09-15 | 3 | 28 | 10 | 19.333 | 6.85 | 182.23% |
| 2022-11-17 | 4 | 28 | 10 | 19.250 | 4.45 | 332.58% |
KMPH Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 4 | 0 | 0 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
KMPH's average broker recommendation rating improved by 0 over the prior 44 weeks.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- To contextualize these metrics, consider that out of all US stocks, KEMPHARM INC's number of analysts covering the stock is greater than 39.64% of them.
- In terms of how KEMPHARM INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 435.32% of that group.
- In terms of how KEMPHARM INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -325.43% of that group.
- In terms of how KEMPHARM INC fares relative to Healthcare stocks, note that its average analyst price target is greater than 171.63% of that group.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to KEMPHARM INC are KALV, XBIT, and GLYC.
View All Top Stocks by Price Target
What is the outlook for KMPH? Use POWR Ratings for clearer insight into price direction.